======= EYA2 ======= == Gene Information == * **Official Symbol**: EYA2 * **Official Name**: EYA transcriptional coactivator and phosphatase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2139|2139]] * **UniProt**: [[https://www.uniprot.org/uniprot/O00167|O00167]] * **Interactions**: [[https://thebiogrid.org/search.php?search=EYA2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20EYA2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601654|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the eyes absent (EYA) family of proteins. The encoded protein may be post-translationally modified and may play a role in eye development. A similar protein in mice can act as a transcriptional activator. Alternative splicing results in multiple transcript variants, but the full-length natures of all of these variants have not yet been determined. [provided by RefSeq, Jul 2009]. * **UniProt Summary**: N/A |Hydrolase| |histone dephosphorylation| |mesodermal cell fate specification| |mesodermal cell fate commitment| |mitochondrial outer membrane permeabilization| |positive regulation of mitochondrial membrane permeability involved in apoptotic process| |mitochondrial outer membrane permeabilization involved in programmed cell death| |positive regulation of mitochondrial membrane permeability| |regulation of mitochondrial membrane permeability involved in apoptotic process| |positive regulation of membrane permeability| |mesodermal cell differentiation| |cell fate commitment involved in formation of primary germ layer| |extrinsic apoptotic signaling pathway in absence of ligand| |signal transduction in absence of ligand| |negative regulation of extrinsic apoptotic signaling pathway in absence of ligand| |negative regulation of signal transduction in absence of ligand| |regulation of extrinsic apoptotic signaling pathway in absence of ligand| |apoptotic mitochondrial changes| |positive regulation of DNA repair| |mesoderm formation| |mesoderm morphogenesis| |regulation of mitochondrial membrane permeability| |regulation of membrane permeability| |cell fate specification| |extrinsic apoptotic signaling pathway| |positive regulation of response to DNA damage stimulus| |protein tyrosine phosphatase activity| |negative regulation of extrinsic apoptotic signaling pathway| |peptidyl-tyrosine dephosphorylation| |formation of primary germ layer| |mesoderm development| |regulation of DNA repair| |mitochondrial membrane organization| |regulation of extrinsic apoptotic signaling pathway| |gastrulation| |positive regulation of DNA metabolic process| |protein dephosphorylation| |magnesium ion binding| |mitochondrial transport| |regulation of response to DNA damage stimulus| |negative regulation of apoptotic signaling pathway| |cell fate commitment| |striated muscle tissue development| |apoptotic signaling pathway| |muscle tissue development| |dephosphorylation| |transcription factor binding| |regulation of DNA metabolic process| |histone modification| |covalent chromatin modification| |regulation of apoptotic signaling pathway| |mitochondrion organization| |DNA repair| |tissue morphogenesis| |embryonic morphogenesis| |chromatin organization| |regulation of cellular response to stress| |DNA metabolic process| |cellular response to DNA damage stimulus| |membrane organization| |negative regulation of apoptotic process| |anatomical structure formation involved in morphogenesis| |negative regulation of programmed cell death| |apoptotic process| |embryo development| |negative regulation of cell death| |programmed cell death| |chromosome organization| |cell death| |mitochondrion| |negative regulation of signal transduction| |negative regulation of cell communication| |negative regulation of signaling| |regulation of response to stress| |regulation of apoptotic process| |regulation of programmed cell death| |negative regulation of response to stimulus| |regulation of cell death| |cellular response to stress| |tissue development| |positive regulation of nucleobase-containing compound metabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp517|Quercetin 20μM R08 exp517]]|-2.43| |[[:results:exp433|LJH685 50μM R08 exp433]]|-1.93| |[[:results:exp222|Betulinic acid 10 to 15μM on day4 R05 exp222]]|-1.7| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|1.83| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9902 * **Expression level (log2 read counts)**: -4.01 {{:chemogenomics:nalm6 dist.png?nolink |}}